Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study.

The aim of this study was to determine the risk of irritable bowel syndrome (IBS) diagnosis in patients with celiac disease (CD) compared with general population comparators. Using Swedish histopathology and register-based data, we identified fi ed 27,262 patients with CD diagnosed in 2002-2017 - 2017 and 132,922 age- and sex-matched general population comparators. Diagnoses of IBS were obtained from nationwide inpatient and non-primary outpatient records. Cox regression estimated hazard ratios (aHRs) for IBS adjusted for education level and Charlson Comorbidity Index. To reduce potential surveillance bias our analyses considered incident IBS diagnosis >= 1 year after CD diagnosis. Using conditional logistic regression, secondary analyses were calculated to estimate odds ratios (ORs) for IBS diagnosis >= 1 year before CD diagnosis. RESULTS: During an average of 11.1 years of follow-up, 732 celiac patients (2.7%) were diagnosed with IBS vs 1131 matched general population comparators (0.9%). Overall (>= 1 >= 1-year of follow-up), the aHR for IBS was 3.11 (95% confidence fi dence interval [CI], 2.83-3.42), - 3.42), with aHR of 2.00 (95% CI, 1.63-2.45) - 2.45) after >= 10 years of follow-up. Compared with siblings (n = 32,010), celiac patients (n = 19,211) had >= 2-fold risk of later IBS (aHR, 2.42; 95% CI, 2.08-2.82). - 2.82). Compared with celiac patients with mucosal healing, those with persistent villus atrophy on follow-up biopsy were less likely to be diagnosed with IBS (aHR, 0.66; 95% CI, 0.46-0.95). - 0.95). CD was also associated with having an earlier IBS diagnosis (OR, 3.62; 95% CI, 3.03-4.34). - 4.34). CONCLUSIONS: In patients with CD, the risk of IBS is increased long before and after diagnosis. Clinicians should be aware of these long-term associations and their implications on patient management.